282 related articles for article (PubMed ID: 28963701)
1. Biophysical Aspects of Alzheimer's Disease: Implications for Pharmaceutical Sciences : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.
Arosio P
Pharm Res; 2017 Dec; 34(12):2628-2636. PubMed ID: 28963701
[TBL] [Abstract][Full Text] [Related]
2. Endothelial LRP1 - A Potential Target for the Treatment of Alzheimer's Disease : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.
Storck SE; Pietrzik CU
Pharm Res; 2017 Dec; 34(12):2637-2651. PubMed ID: 28948494
[TBL] [Abstract][Full Text] [Related]
3. Disease-Induced Alterations in Brain Drug Transporters in Animal Models of Alzheimer's Disease : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.
Vellonen KS; Ihalainen J; Boucau MC; Gosselet F; Picardat T; Gynther M; Kanninen KM; White AR; Malm T; Koistinaho J; Forsberg MM; Ruponen M
Pharm Res; 2017 Dec; 34(12):2652-2662. PubMed ID: 28952054
[TBL] [Abstract][Full Text] [Related]
4. β-sheet interfering molecules acting against β-amyloid aggregation and fibrillogenesis.
Francioso A; Punzi P; Boffi A; Lori C; Martire S; Giordano C; D'Erme M; Mosca L
Bioorg Med Chem; 2015 Apr; 23(8):1671-83. PubMed ID: 25769517
[TBL] [Abstract][Full Text] [Related]
5. Anti-amyloid Aggregation Activity of Natural Compounds: Implications for Alzheimer's Drug Discovery.
Bu XL; Rao PPN; Wang YJ
Mol Neurobiol; 2016 Aug; 53(6):3565-3575. PubMed ID: 26099310
[TBL] [Abstract][Full Text] [Related]
6. Not Oligomers but Amyloids are Cytotoxic in the Membrane-Mediated Amyloidogenesis of Amyloid-β Peptides.
Itoh N; Takada E; Okubo K; Yano Y; Hoshino M; Sasaki A; Kinjo M; Matsuzaki K
Chembiochem; 2018 Mar; 19(5):430-433. PubMed ID: 29235220
[TBL] [Abstract][Full Text] [Related]
7. The contribution of biophysical and structural studies of protein self-assembly to the design of therapeutic strategies for amyloid diseases.
Cremades N; Dobson CM
Neurobiol Dis; 2018 Jan; 109(Pt B):178-190. PubMed ID: 28709995
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Interventions for the Suppression of Alzheimer's Disease: Quest for a Remedy.
Fazili NA; Naeem A; Ashraf GM; Hua GS; Kamal MA
Curr Drug Metab; 2015; 16(5):346-53. PubMed ID: 25429669
[TBL] [Abstract][Full Text] [Related]
9. Nanomedicine for the treatment of Alzheimer's disease.
Gregori M; Masserini M; Mancini S
Nanomedicine (Lond); 2015; 10(7):1203-18. PubMed ID: 25929574
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Alzheimer's amyloid-beta aggregation in-vitro by carbenoxolone: Insight into mechanism of action.
Sharma S; Nehru B; Saini A
Neurochem Int; 2017 Sep; 108():481-493. PubMed ID: 28652220
[TBL] [Abstract][Full Text] [Related]
11. Elucidating the Structures of Amyloid Oligomers with Macrocyclic β-Hairpin Peptides: Insights into Alzheimer's Disease and Other Amyloid Diseases.
Kreutzer AG; Nowick JS
Acc Chem Res; 2018 Mar; 51(3):706-718. PubMed ID: 29508987
[TBL] [Abstract][Full Text] [Related]
12. NABi, a novel β-sheet breaker, inhibits Aβ aggregation and neuronal toxicity: Therapeutic implications for Alzheimer's disease.
Jang JY; Rhim H; Kang S
Biochim Biophys Acta Gen Subj; 2018 Jan; 1862(1):71-80. PubMed ID: 29107146
[TBL] [Abstract][Full Text] [Related]
13. Drug discovery, development and delivery in Alzheimer's disease.
Brambilla D
Pharm Res; 2017 Dec; 35(1):3. PubMed ID: 29288429
[No Abstract] [Full Text] [Related]
14. Current thinking on the mechanistic basis of Alzheimer's and implications for drug development.
Ising C; Stanley M; Holtzman DM
Clin Pharmacol Ther; 2015 Nov; 98(5):469-71. PubMed ID: 26250900
[TBL] [Abstract][Full Text] [Related]
15. Screening strategies to identify HSP70 modulators to treat Alzheimer's disease.
Repalli J; Meruelo D
Drug Des Devel Ther; 2015; 9():321-31. PubMed ID: 25609918
[TBL] [Abstract][Full Text] [Related]
16. Phytomedicines as potential inhibitors of β amyloid aggregation: significance to Alzheimer's disease.
Kumar NS; Nisha N
Chin J Nat Med; 2014 Nov; 12(11):801-18. PubMed ID: 25480511
[TBL] [Abstract][Full Text] [Related]
17. Amyloidogenesis of Tau protein.
Nizynski B; Dzwolak W; Nieznanski K
Protein Sci; 2017 Nov; 26(11):2126-2150. PubMed ID: 28833749
[TBL] [Abstract][Full Text] [Related]
18. Amyloid cascade in Alzheimer's disease: Recent advances in medicinal chemistry.
Mohamed T; Shakeri A; Rao PP
Eur J Med Chem; 2016 May; 113():258-72. PubMed ID: 26945113
[TBL] [Abstract][Full Text] [Related]
19. Amyloid Fibres: Inert End-Stage Aggregates or Key Players in Disease?
Tipping KW; van Oosten-Hawle P; Hewitt EW; Radford SE
Trends Biochem Sci; 2015 Dec; 40(12):719-727. PubMed ID: 26541462
[TBL] [Abstract][Full Text] [Related]
20. Graphene quantum dots for the inhibition of β amyloid aggregation.
Liu Y; Xu LP; Dai W; Dong H; Wen Y; Zhang X
Nanoscale; 2015 Dec; 7(45):19060-5. PubMed ID: 26515666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
